{"id":"hlx301","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T04:31:02.829Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:52:00.447717+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05390528","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma","status":"UNKNOWN","sponsor":"Shanghai Henlius Biotech","startDate":"2022-06-20","conditions":"Advanced Tumors, Lymphoma, Metastatic Tumors","enrollment":30},{"nctId":"NCT05102214","phase":"PHASE1, PHASE2","title":"HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors","status":"UNKNOWN","sponsor":"Shanghai Henlius Biotech","startDate":"2022-05-03","conditions":"Locally Advanced or Metastatic Solid Tumors, Non-small Cell Lung Cancer","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["A Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody"],"phase":"phase_1","status":"active","brandName":"HLX301","genericName":"HLX301","companyName":"Shanghai Henlius Biotech","companyId":"shanghai-henlius-biotech","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:52:00.447717+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}